MY ACCOUNT | NEWSLETTER |

Advances in equine juvenile idiopathic epilepsy


Seizures are relatively uncommon in horses when compared with other species. In equines, seizure activity can be caused by conditions such as septicemia, hypoxic ischemic encephalopathy, metabolic disturbances, including electrolyte imbalances and hypoglycemia, bacterial or viral meningitis, certain medications, liver failure, trauma, and congenital anomalies.

Epilepsy is characterized by recurrent seizures without a precipitating factor, and the International League Against Epilepsy (ILAE) classifies the condition in humans as generalized, localized, and unclassified. Further subdivisions include idiopathic (i.e. primary) and symptomatic (i.e. secondary). Classifying epileptic events is helpful to promote clinical research studies, determine an appropriate treatment protocol, and establish a prognosis.

Although epilepsy is rarely documented in horses, Arabian foals from certain familial lines exhibit a condition known as equine juvenile idiopathic epilepsy (JIE). Recent research has provided new information about this interesting seizure condition.

Equine juvenile idiopathic epilepsy overview

JIE is a hereditary seizure disorder some Arabian foals of Egyptian lineage develop. The condition most often occurs between birth to 6 months of age. An affected foal may experience tonic-clonic seizures that can last as long as five minutes, putting them at risk for secondary complications such as temporary blindness, lethargy, and disorientation. Other more serious complications, such as head injuries and aspiration pneumonia, can also occur. Between seizures, an affected foal exhibits no abnormal signs. Some foals outgrow the condition, but others die or experience lifelong effects. Other JIE factors include:

  • Diagnosis — JIE is diagnosed by electroencephalogram (EEG), which measures a foal’s electrical brain activity. Affected foals have characteristic abnormalities in the parietal parasagittal region. Additional clinical and laboratory tests are performed to rule out other potential seizure causes.
  • Treatment — Benzodiazepines can be used as a short-term treatment for seizures. The dosage in foals is 0.05 to 0.4 mg/kg, and the dose can be repeated in 30 minutes if necessary. Phenobarbital is usually the drug of choice for long-term seizure management. The recommended loading dose is 12 to 20 mg/kg intravenous (IV) phenobarbital diluted in one liter of saline or dextrose over a 30-minute period, followed by 6 to 12 mg/kg phenobarbital by mouth every 12 hours. Potassium bromide or levetiracetam can also be used in difficult-to-control cases.
  • Management — Devices, such as headgear, padded stalls, and deep bedding, should be provided until the seizures are effectively controlled by medication.
  • Prevention — To prevent the disorder from perpetuating, affected animals should not be bred.

Investigation of known genetic mutations of Arabian horses in Egyptian foals with juvenile idiopathic epilepsy

JIE is believed to have an autosomal dominant mode of inheritance, but the genetic cause is unknown. One theory postulated that an association exists between JIE and lavender foal syndrome (LFS), but a 2018 University of California (UC) Davis study established that the two conditions are independent syndromes. The UC Davis study details include:

  • Hypothesis — Researchers wanted to determine LFS’s carrier status, cerebellar abiotrophy (CA), severe combined immunodeficiency (SCID), and occipitoatlantoaxial malformation (OAAM1) in foals affected by JIE.
  • Materials and methods — The researchers tested archived DNA samples for known genetic mutations causing LFS, CA, SCID, and OAAM1. Foals included in the study were diagnosed with JIE based on EEG findings and by ruling out other causes.
  • Results — Ten Egyptian Arabian foals were phenotyped as having JIE by EEG. All were negative for genetic mutations that cause LFS, CA, SCID, and OAAM1 except for one foal who was a CA carrier.
  • Conclusions — JIE in Egyptian Arabian foals appears to be a phenotypically and genetically distinct disorder from LFS, and no apparent link exists between JIE and CA, SCID, or OAAM1.

TRIM39–RPP21 variants are not associated with juvenile idiopathic epilepsy in Egyptian Arabian horses

A 2019 study investigated whether a 19 base pair deletion, along with a triple-C insertion, in intron 5 of 12 of the Tripartite Motif-Containing 39 Ribonuclease p/mrp 21kDa subunit (TRIM39-RPP21) gene was associated with JIE. In an attempt to confirm this association, researchers genotyped nine EEG-phenotyped JIE-affected foals and nine unaffected foals using Sanger sequencing. They found no significant genotypic or allelic association with the variants and JIE. Researchers concluded that the TRIM39-RPP21 variant is a common variant that happens to be positioned in a highly polymorphic region in the Arabian breed.

Sequence variant in the TRIM39-RPP21 gene readthrough is shared across a cohort of Arabian foals with juvenile idiopathic epilepsy

A 2022 study aimed to identify genetic components shared across a local cohort of Arabian foals with JIE. Researchers conducted whole genome comparisons between nine JIE foals and 27 controls, revealing variants uniquely shared among the nine JIE foals. They also conducted targeted sequencing on these variants to validate their results. Researchers found a single 19bp deletion coupled with a triple-C insertion within the TRIM39-RPP21 gene readthrough the JIE foals shared. Further research is needed to determine if the variant is a credible marker for JIE.

Juvenile idiopathic epilepsy in Arabian horses is not a single-gene disorder

In May 2023, researchers published their findings on whether JIE is a single-gene trait. They conducted a genome-wide association study (GWAS) on 60 JIE cases and 120 genetically matched controls. Researchers identified loci that suggested JIE is not caused by a single locus. Coat color (i.e., chestnut and grey) phenotypes were used as positive control traits to assess the population’s GWAS efficacy. Researchers plan to perform future studies to define candidate regions and explore a polygenic inheritance mode.

Research studies such as these help expand knowledge about JIE to hopefully help find a credible marker for the condition and potentially prevent future cases.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Evaluation of 3D additively manufactured canine brain models for teaching veterinary neuroanatomy

Like0
Dislike0

Reasons for whole carcass condemnations of cattle in the United States and implications for producer education and veterinary intervention

Like0
Dislike0

A New Penn Vet Clinic Brings Support and Hope for Dogs with Retinal Disease

Like0
Dislike0

Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™ to Advance Development of a Pan-Target, Programmable Therapeutic

Like0
Dislike0

Cooperation in regional innovation networks among small and medium enterprises: Case study of a veterinary pharmaceutical company in Jalisco, Mexico

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top